Vantage Consulting Group Inc
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 6, 2025), Vantage Consulting Group Inc reported 3 stock positions worth $11.2 million. Its top holding was Babcock & Wilcox Enterpr (BW) at 62.5% of the portfolio, followed by Adc Therapeutics (ADCT, 24.4%) and Cibus (CBUS, 13.2%). Its holdings were unchanged from Q2 2025.
- Most Recent 13F
- Q4 2025
- Location
- VIRGINIA BEACH, VA
- CIK
- 0001843547
- Portfolio Value
- $11.2M (Q3 2025)
- SEC Filing
- 0001843547-25-000016 ↗ filed Nov 6, 2025
Holdings Value
Holdings 3 stocks · $11.2M
Portfolio Sells Q2 2025 → Q3 2025
| None this quarter. | |||
Portfolio Buys Q2 2025 → Q3 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q4 2025 | 3 | $19.7M | BW, ADCT, CBUS |
| Q3 2025 | 3 | $11.2M | BW, ADCT, CBUS |
| Q2 2025 | 3 | $5.7M | BW, ADCT, CBUS |
| Q1 2025 | 4 | $5.0M | CBUS, BW, ADCT, FIBROGEN INC |
| Q4 2024 | 5 | $10.5M | BW, CBUS, ADCT, PBPB, FIBROGEN INC |
| Q3 2024 | 4 | $11.4M | BW, CBUS, ADCT, FIBROGEN INC |
| Q2 2024 | 191 | $134.6M | SYNTAX STRATIFIED LARGE CAP, CBUS, SMDY, BW, SSLY |
| Q1 2024 | 212 | $157.3M | SYNTAX STRATIFIED LARGE CAP, CBUS, SMDY, ADCT, SSLY |